Lucki, Irwin

Assessing antidepressant activity in rodents: recent developments and future needs

Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 1,551

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects

Hoshaw, B. A., Malberg, J. E., & Lucki, I. (2005) · Brain Research

Treatment of Major DepressionNerve injury and regeneration

Cited by 348

Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment

Cryan, J. F., Page, M. E., & Lucki, I. (2005) · Psychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 321

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants

Browne, C. A., & Lucki, I. (2013) · Frontiers in Pharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 285

Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments

Balu, D. T., Hoshaw, B. A., Malberg, J. E., Rosenzweig-Lipson, S., Schechter, L. E., & Lucki, I. (2008) · Brain Research

Treatment of Major DepressionNerve injury and regeneration

Cited by 194

Chronic use of benzodiazepines and psychomotor and cognitive test performance

Lucki, I., Rickels, K., & Geller, A. (1986) · Psychopharmacology

Substance Abuse Treatment and OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 186

Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors

Falcon, E., Browne, C. A., Leon, R. M., Fleites, V. C., Sweeney, R., Kirby, L. G., & Lucki, I. (2016) · Neuropsychopharmacology

Neuropeptides and Animal PhysiologyTreatment of Major Depression

Cited by 118

Increasing the Levels of Insulin-Like Growth Factor-I by an IGF Binding Protein Inhibitor Produces Anxiolytic and Antidepressant-Like Effects

Malberg, J. E., Platt, B., Rizzo, S. J. S., Ring, R. H., Lucki, I., Schechter, L. E., & Rosenzweig-Lipson, S. (2007) · Neuropsychopharmacology

Growth Hormone and Insulin-like Growth FactorsTreatment of Major Depression

Cited by 101

Pharmacogenomic evaluation of the antidepressant citalopram in the mouse tail suspension test

Crowley, J. J., Brodkin, E. S., Blendy, J. A., Berrettini, W. H., & Lucki, I. (2006) · Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 61

Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission

Hoshaw, B. A., Hill, T. I., Crowley, J. J., Malberg, J. E., Khawaja, X., Rosenzweig-Lipson, S., Schechter, L. E., & Lucki, I. (2008) · European Journal of Pharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 60

Psychomotor Performance of Long-Term Benzodiazepine Users Before, During, and After Benzodiazepine Discontinuation

Rickels, K., Lucki, I., Schweizer, E., Garcia-Espana, F., & Case, W. G. (1999) · Journal of Clinical Psychopharmacology

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 49

Anxiolytic effect of serotonin depletion in the novelty-induced hypophagia test

Bechtholt, A. J., Hill, T. E., & Lucki, I. (2007) · Psychopharmacology

Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology Research

Cited by 48

Overlapping and Distinct Brain Regions Associated with the Anxiolytic Effects of Chlordiazepoxide and Chronic Fluoxetine

Bechtholt, A. J., Valentino, R. J., & Lucki, I. (2008) · Neuropsychopharmacology

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 40